A platform-based regulatory management of recurrent vaccine composition updates using the Post‑Approval Change Management Protocol (PACMP)—The regulatory framework for seasonal influenza vaccines and COVID-19 vaccines in Japan
A platform-based regulatory management of recurrent vaccine composition updates using the Post‑Approval Change Management Protocol (PACMP)—The regulatory framework for seasonal influenza vaccines and COVID-19 vaccines in Japan. // Vaccine: X. – URL: https://www.sciencedirect.com/science/article/pii/S2590136226001087?dgcid=rss_sd_all
A platform-based regulatory management of recurrent vaccine composition updates using the Post‑Approval Change Management Protocol (PACMP)—The regulatory framework for seasonal influenza vaccines and COVID-19 vaccines in Japan. Vaccine: X. https://www.sciencedirect.com/science/article/pii/S2590136226001087?dgcid=rss_sd_all
“A platform-based regulatory management of recurrent vaccine composition updates using the Post‑Approval Change Management Protocol (PACMP)—The regulatory framework for seasonal influenza vaccines and COVID-19 vaccines in Japan.” Vaccine: X.
@article{article7372,
title = {A platform-based regulatory management of recurrent vaccine composition updates using the Post‑Approval Change Management Protocol (PACMP)—The regulatory framework for seasonal influenza vaccines and COVID-19 vaccines in Japan},
journal = {Vaccine: X},
url = {https://www.sciencedirect.com/science/article/pii/S2590136226001087?dgcid=rss_sd_all}
}